IGH for B-Cell Chronic Lymphocytic Leukemia (B-CLL), Somatic Hypermutation Analysis
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Prognostic information in patients with newly diagnosed B-cell chronic lymphocytic leukemia
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Polymerase Chain Reaction (PCR)/Sequencing/Comparison with IMGT Database for Mutation Status
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
IGH Somatic Hypermutation in B-CLL